Founder of Clarety Flow, business strategy advisor, and board member for technology companies. Currently teamed up with globally recognized drug development scientists to bring to market a $300 million alternative investment vehicle that de-risks pharmaceutical project finance.
An investment banker and advisor to companies including multinationals and sector-leading services companies, as well as state and national governments. Specialties included public-private partnerships, pharmaceutical strategies, regulatory and tax, customer value management, and platform ecosystem strategies. Banking experience includes financial modeling, valuation, public company and precedent transaction anal...
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
